Effects of coenzyme Q10 supplementation on serum values of adiponectin, leptin, 8-isoprostane and malondialdehyde in women with type 2 diabetes

References

• Chan DC, Pang J, Watts GF. Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10? Curr Atheroscler Rep. 2015;17:472.
   PubMed Web of Science ®Google Scholar
• Shen Q, Pierce JD. Supplementation of coenzyme Q10 among patients with type 2 diabetes mellitus. Healthcare (Basel). 2015;3:296–309.
   PubMedGoogle Scholar
• Farooq R, Amin S, Hayat Bhat M, et al. Type 2 diabetes and metabolic syndrome - adipokine levels and effect of drugs. Gynecol Endocrinol. 2017;33:75–78.
   PubMed Web of Science ®Google Scholar
• López-Jaramillo P, Gómez-Arbeláez D, López-López J, et al. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Horm Mol Biol Clin Investig. 2014;18:37–45.
   PubMedGoogle Scholar
• Katsiki N, Mantzoros C, Mikhailidis DP. Adiponectin, lipids and atherosclerosis. Curr Opin Lipidol. 2017;28:347–354.
   PubMed Web of Science ®Google Scholar
• Rühl R, Landrier JF. Dietary regulation of adiponectin by direct and indirect lipid activators of nuclear hormone receptors. Mol Nutr Food Res. 2016;60:175–184.
   PubMed Web of Science ®Google Scholar
• Inoue M, Maehata E, Yano M, et al. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism. 2005;54:281–286.
   PubMed Web of Science ®Google Scholar
• Jung CH, Rhee EJ, Choi JH, et al. The relationship of adiponectin/leptin ratio with homeostasis model assessment insulin resistance index and metabolic syndrome in apparently healthy Korean male adults. Korean Diabetes J. 2010;34:237–243.
   PubMedGoogle Scholar
• Ding YS, Guo SX, Ma RL, et al. Association of metabolic syndrome with the adiponectin to homeostasis model assessment of insulin resistance ratio. Mediators Inflamm. 2015;2015:607364.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:S81–S90.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Forsberg E, Xu C, Grünler J, et al. Coenzyme Q10 and oxidative stress, the association with peripheral sensory neuropathy and cardiovascular disease in type 2 diabetes mellitus. J Diabetes Complication. 2015;29:1152–1158.
   PubMed Web of Science ®Google Scholar
• Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86:271–278.
   PubMed Web of Science ®Google Scholar
• Mohammad Shahi M, Zakerzadeh M, Zakerkish M, et al. Effect of sesamin supplementation on glycemic status, inflammatory markers, and adiponectin levels in patients with type 2 diabetes mellitus. J Diet Suppl. 2017;14:65–75.
   PubMedGoogle Scholar
• Moazen M, Mazloom Z, Ahmadi A, et al. Effect of coenzyme Q10 on glycaemic control, oxidative stress and adiponectin in type 2 diabetes. J Pak Med Assoc. 2015;65:404–408.
   PubMed Web of Science ®Google Scholar
• Kaviarasan S, Muniandy S, Qvist R, et al. F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a review. J Clin Biochem Nutr. 2009;45:1–8.
   PubMed Web of Science ®Google Scholar
• Marrocco I, Altieri F, Peluso I. Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev. 2017;2017:6501046.
   PubMed Web of Science ®Google Scholar
• Raygan F, Rezavandi Z, Dadkhah Tehrani S, et al. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome. Eur J Nutr. 2016;55:2357–2364.
   PubMed Web of Science ®Google Scholar
• Gökbel H, Gergerlioğlu HS, Okudan N, et al. Effects of coenzyme Q10 supplementation on plasma adiponectin, interleukin-6, and tumor necrosis factor-alpha levels in men. J Med Food. 2010;13:216–218.
   PubMed Web of Science ®Google Scholar
• Farsi F, Mohammadshahi M, Alavinejad P, et al. Functions of coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr. 2016;35:346–353.
   PubMed Web of Science ®Google Scholar
• Picu A, Petcu L, Ştefan S, et al. Markers of oxidative stress and antioxidant defense in romanian patients with type 2 diabetes mellitus and obesity. Molecules. 2017;22:714.
   PubMed Web of Science ®Google Scholar
• Fan L, Feng Y, Chen GC, et al. Effects of coenzyme Q10 supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2017;119:128–136.
   PubMed Web of Science ®Google Scholar
• Zhai J, Bo Y, Lu Y, et al. Effects of coenzyme Q10 on markers of inflammation: a systematic review and meta-analysis. PloS One. 2017;12:e0170172.
   PubMed Web of Science ®Google Scholar
• Ren Y, Li Y, Yan J, et al. Adiponectin modulates oxidative stress-induced mitophagy and protects C2C12 myoblasts against apoptosis. Sci Rep. 2017;7:3209.
   PubMed Web of Science ®Google Scholar
• Liu C, Feng X, Li Q, et al. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis. Cytokine. 2016;86:100–109.
   PubMed Web of Science ®Google Scholar
• Goto A, Noda M, Goto M, et al. Plasma adiponectin levels, ADIPOQ variants, and incidence of type 2 diabetes: a nested case-control study. Diabetes Res Clin Pract. 2017;127:254–264.
   PubMed Web of Science ®Google Scholar
• Frühbeck G, Catalán V, Rodríguez A, et al. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome. Sci Rep. 2017;7:6619.
   PubMed Web of Science ®Google Scholar
• Amin MM, Asaad GF, Salam RMA, et al. Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats. PloS One. 2014;9:e89169.
   PubMed Web of Science ®Google Scholar
• Chruściel P, Sahebkar A, Rembek-Wieliczko M, et al. Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis. 2016;253:194–208.
   PubMed Web of Science ®Google Scholar